News | News By Subject | News by Disease News By Date | Search News

Pancreatic Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Momenta (MNTA) Halts Enrollment in Necuparanib Phase II Per Recommendation From the Independent Data Safety Monitoring Board     8/4/2016
Aduro Biotech (ADRO)'s Stock Craters After Pancreatic Cancer Drug Trial Misses Primary Endpoint     5/17/2016
NewLink Genetics (NLNK) Craters as Pancreatic Cancer Vaccine Fails Phase III Study, May Even Harm Patients     5/10/2016
Investors Hold Their Breath for Data from Aduro Biotech (ADRO), Novartis AG (NVS)     3/11/2016
Incyte (INCY) Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors     2/12/2016
Independent Experts Say Bay Area's OncoMed (OMED)'s Pancreatic Cancer Drug Unlikely to Succeed in Phase II Study     1/25/2016
RestorGenex (RESX) and Diffusion Pharma Merge to Form Wholly-Owned Oncology Subsidiary     12/28/2015
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures     12/7/2015
Former Biogen (BIIB) Exec Doug Williams to Head Startup Codiak BioSciences     11/18/2015
SoCal's Halozyme (HALO) To Expand With A Satellite Office In San Francisco     11/18/2015
Medivir (MVRBF) Terminates the ADAM8 Inhibitor Project for Pancreatic Cancer     11/17/2015
Momenta (MNTA) Puts a Temporary Hold on Enrollment in Phase II Necuparanib Study to Discuss Specific Toxicities     11/13/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
OncoGenex (OGXI) Stock Plummets After Pancreatic Cancer Drug Misses Mark in Phase II Study     9/24/2015
Sun Pharma (SUNPHARMA.NS) Appoints David Kaysen as CEO Amidst Equity Activity and Phase I Pancreas Cancer Trials     9/16/2015

News from Around the Web
Led by Former Eli Lilly (LLY) Exec, Apexian Out to Tackle Pancreatic Cancer     11/16/2016
Why Is Pancreatic Cancer So Hard To Kill?     10/4/2016
Oral Bacteria May Help Spot Pancreatic Cancer, New York University Study     4/20/2016
Engineering T Cells To Treat Pancreatic Cancer, Fred Hutchinson Cancer Research Center Study     4/19/2016
Implantable Device Targets Pancreatic Cancer, MIT Study     4/18/2016
Magnesium May Lower Pancreatic Cancer Risk, Indiana University Researchers Find     1/4/2016
New Test May Improve Diagnosis And Treatment Of Pancreatobiliary And Other Gastrointestinal Cancers, University of Chicago Study     11/24/2015
3-D Pancreatic Cancer Organoid May Help Predict Clinical Responses, Nature Medicine Publishes     10/28/2015
Early Stage Pancreatic Cancer Urine Test Possible After Biomarker Discovery, Queen Mary University Of London Study     8/3/2015
Tiny Particles In Blood Useful For Early Diagnosis Of Pancreatic Cancer, University of Texas MD Anderson Cancer Center Study     6/25/2015
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/23/2014
Chinese Herbal Extract May Help Kill Off Pancreatic Cancer Cells, American Physiological Society Reveals     7/3/2014
Low-Dose Aspirin Slashes Pancreatic Cancer Risk In Half, Yale University Study     6/30/2014
How Green Tea Upsets Cancer Cell Metabolism, Los Angeles Biomedical Research Institute Study     6/4/2014
Gene Mutation Found for Aggressive Form Of Pancreatic Cancer, University of California, San Diego (UCSD) Study     5/30/2014

Press Releases
Araim Pharmaeuticals Release: ARA 290 Obtains European Union Orphan Drug Designation For Prevention Of Graft Loss In Pancreatic Islet Transplantation     11/28/2016
MabVax Therapeutics Enrolls First Patients In Expansion Of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients     11/28/2016
The Lustgarten Foundation for Pancreatic Cancer Research Release: Half Of Americans Surveyed Think There Is A Pancreatic Cancer Screening Test     11/17/2016
MabVax Therapeutics Reports Interim Safety And Imaging Results From Phase I Clinical Trials In Humab-5B1 Antibody Development Programs     11/14/2016
ARMO BioSciences' Immunotherapy AM0010 Receives Orphan Drug And Fast Track Designations From The U.S. FDA For The Treatment Of Pancreatic Cancer     11/14/2016
Boston Biomedical Announces Orphan Drug Designation For Napabucasin In Pancreatic Cancer     11/14/2016
Cell Culture Company (C3) Deal Targets Pancreatic Cancer     11/10/2016
Onxeo Announces Promising Results From Preclinical Studies Of Livatag In Pancreatic Cancer     11/4/2016
OncoVent Release: Initiates Clinical Development Program For Anti-MUC1 MAb AR20.5 For Treatment Of Pancreatic Cancer     11/2/2016
Mauna Kea Technologies Release: Cellvizio's Strong Clinical Efficacy In The Prevention Of Certain Pancreatic Cancers Confirmed By Positive Results From Contact Study Presented At UEGW 2016     10/19/2016
PharmaEngine, Inc. Announces Onivyde Receives European Marketing Authorization For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas Following Gemcitabine Based Therapy     10/18/2016
Shire (SHPG) Granted EU Marketing Authorization Of Onivyde, In Combination With 5-Fluorouracil (5-FU) And Leucovorin (LV),For The Treatment Of Metastatic Adenocarcinoma Of The Pancreas In Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy     10/18/2016
Ontario Institute for Cancer Research Release: New Findings Published Today In Nature Challenge Current View Of How Pancreatic Cancer Develops     10/13/2016
Merrimack (MACK) Release: Final Results Of NAPOLI-1 Study Confirm Overall Survival And Progression-Free Survival Benefit For The ONIVYDE Regimen For Patients With Metastatic Pancreatic Cancer     10/11/2016
OncoMed (OMED) Presents Interim Phase Ib Data For Ipafricept And Vantictumab In Pancreatic Cancer At The ESMO 2016 Congress     10/10/2016

//-->